Published : Jul-2017
No. of Pages : 78
Table of Contents 2
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by G7 Countries: Proportion of Down Syndrome to Genetic Disorders Clinical Trials 17
Clinical Trials by Phase in G7 Countries 19
Clinical Trials in G7 Countries by Trial Status 20
Clinical Trials by E7 Countries: Proportion of Down Syndrome to Genetic Disorders Clinical Trials 21
Clinical Trials by Phase in E7 Countries 23
Clinical Trials in E7 Countries by Trial Status 24
Clinical Trials by Phase 25
In Progress Trials by Phase 26
Clinical Trials by Trial Status 27
Clinical Trials by End Point Status 29
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Down Syndrome Therapeutics Clinical Trials 34
Prominent Drugs 36
Latest Clinical Trials News on Down Syndrome 37
Jul 11, 2017: QR Pharma Presents New Data on Posiphen in Down Syndrome at the Alzheimer's Disease International Conference 37
May 31, 2017: Clinical trial investigates potential Alzheimers disease drug in people with Down syndrome 37
Clinical Trial Profile Snapshots 38
Appendix 76
Abbreviations 76
Definitions 76
Research Methodology 77
Secondary Research 77
About GlobalData 78
Contact Us 78
Source 78
List of Tables
Down Syndrome Therapeutics, Global, Clinical Trials by Region, 2017* 8
Down Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 10
Down Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11
Down Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 12
Down Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 13
Down Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2017* 14
Down Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 15
Down Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 16
Proportion of Down Syndrome to Genetic Disorders Clinical Trials, G7 Countries (%), 2017* 18
Down Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 19
Down Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 20
Proportion of Down Syndrome to Genetic Disorders Clinical Trials, E7 Countries (%), 2017* 22
Down Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 23
Down Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 24
Down Syndrome Therapeutics, Global, Clinical Trials by Phase, 2017* 25
Down Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 26
Down Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2017* 28
Down Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2017* 29
Down Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 30
Down Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 31
Down Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 33
Down Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 35
Down Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 36
List of Figures
Down Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2017* 8
Down Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Down Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11
Down Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 12
Down Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 13
Down Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 14
Down Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 15
Down Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 16
Proportion of Down Syndrome to Genetic Disorders Clinical Trials, G7 Countries (%), 2017* 17
Down Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 19
Down Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 20
Proportion of Down Syndrome to Genetic Disorders Clinical Trials, E7 Countries (%), 2017* 21
Down Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 23
Down Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 24
Down Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2017* 25
Down Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 26
Down Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2017* 27
Down Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2017* 29
Down Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 30
Down Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 31
Down Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 32
Down Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 34
Down Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 36
GlobalData Methodology 77
